MOMolina Healthcare MOH · NYSE
$198.89 +0.40% (+$0.79)
- Market cap
- $10.4B
- Enterprise value
- $9.85B
- P/E
- -
- Forward P/E
- 37.5x
- PEG
- -
- P/S
- 0.2x
- P/FCF
- 43.6x
- EV/EBITDA
- 29.6x
- ROIC
- 3.8%
- Gross margin
- 32.8%
- Net margin
- -0.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.6x
- Beta
- 0.78
- Free float
- 91.7%
About the company
Molina Healthcare, Inc. (MOH) is a company operating in the field of providing healthcare services and healthcare management. The company specializes in offering health insurance and managing healthcare for individuals, families, and communities. Molina Healthcare focuses on ensuring accessible and quality healthcare for its members, particularly those with lower incomes and in need of special care. The company collaborates with healthcare providers and government agencies to optimize the healthcare system. Shares of Molina Healthcare, Inc. (MOH) are publicly traded on the stock exchange and represent a significant player in the healthcare services and care management sector.
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Joseph Michael Zubretsky
Employees
19,000
Headquarters
Long Beach
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 12% a year over the last 3 years.
- What to watch: Earnings per share fell by 13% a year over the last 3 years.
- What to watch: It missed profit estimates 4 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $4.48B against $3.95B.
- What to watch: Operating profit does not even cover the interest on its debt.
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It bought back its own shares for $1.00B in the last fiscal year, 9.6% of its market value.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number